StockComparison Logo
vs

RENB vs ESLA

Comparison between (RENB, Company) and Estrella Immunopharma Inc (ESLA, Company).

RENB vs ESLA - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
RENB
$32M
Winner
ESLA
$32M
Max Drawdown
RENB
N/A
ESLA
96.58%
Sharpe Ratio
RENB
0.00
Winner
ESLA
0.38
5Y Beta
RENB
N/A
ESLA
0.49
Industry
RENB
N/A
ESLA
Biotechnology
P/E Ratio
RENB
-0.18
Winner
ESLA
-1.95
PEG Ratio
RENB
N/A
ESLA
-0.03
Debt to Equity
RENB
0.28%
Winner
ESLA
0.00%
Free Cash Flow Yield
Winner
RENB
-22.54%
ESLA
-25.01%
P/S Ratio
RENB
138.82
ESLA
N/A
P/B Ratio
Winner
RENB
-2.45
ESLA
4.13

RENB vs ESLA - Historical Returns

Returns include dividend reinvestment.

1M
RENB
N/A
ESLA
-20.41%
3M
RENB
N/A
ESLA
-50.63%
6M
RENB
N/A
ESLA
-22.77%
1Y
RENB
N/A
ESLA
-17.85%
5Y(CAGR)
RENB
N/A
ESLA
-40.55%
Max(CAGR)
Winner
RENB
+51169209385514262528.00%
ESLA
-40.55%

RENB vs ESLA - Annual Returns (2021 - 2026)

Returns include dividend reinvestment.

YearRENBESLA
2026N/A-43.88%
2025+11.81%+39.27%
2024N/A+4.35%
2023N/A-89.17%
2022N/A+3.83%
2021N/A+1.64%

RENB vs ESLA Drawdown Comparison

The maximum drawdown for ESLA was -96.58%, occurring on Nov 1, 2024. This drawdown has not yet recovered.

The current ESLA drawdown is -96.33%.

RankRENBESLA
#1N/A-96.58%
Sep 1, 2023 - Nov 1, 2024
#2N/A-35.78%
Aug 1, 2023 - Sep 1, 2023
#3N/A-9.91%
Jul 17, 2023 - Aug 1, 2023
#4N/A-4.95%
May 25, 2022 - Jan 30, 2023
#5N/A-4.36%
May 16, 2023 - Jul 14, 2023
#6N/A-2.72%
Jan 31, 2023 - Feb 13, 2023
#7N/A-2.46%
Jan 4, 2022 - May 25, 2022
#8N/A-2.24%
Feb 13, 2023 - May 9, 2023
#9N/A-1.30%
Nov 26, 2021 - Jan 4, 2022
#10N/A-0.46%
May 12, 2023 - May 16, 2023
#11N/A-0.40%
Oct 28, 2021 - Nov 26, 2021
#12N/A-0.31%
Sep 21, 2021 - Sep 28, 2021
#13N/A-0.20%
Sep 29, 2021 - Oct 27, 2021

Correlation

Correlation between RENB and ESLA is 0.00 which considered as a very weak or no correlation - the stocks move independently of each other.

0.00
-101

Select Stocks to Compare